Many people ask whether they can pause treatment after reaching their goal or use these medications temporarily rather than long-term
Your first appointment is a real conversation with Dr
On April 30, 2026, the FDA moved further - formally proposing to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List entirely, citing no clinical need for large-scale outsourcing facilities to compound these drugs from bulk substances
Yes, especially if you were prediabetic before starting, or if urination is excessive (more than 3 liters daily or urgent every hour)
Safe Administration It is essential to follow the correct steps for safe administration of tirzepatide as listed below (1-5): The recommended starting dosage is 2.5mg, injected subcutaneously once weekly
Most commonly mild nausea and GI discomfort during the first weeks of titration